Back to resources

Thought Leadership Expertise

Press Room

Cell and Gene Collaborative's COGs: Words Of Wisdom To ‘Keep The End In Mind'

Cell and Gene Collaborative's "New Year's Resolutions"

COGS crisis: Cell therapy sector must rethink CMC, says expert

Brent Morse and Nate Manley on "FDA's Updated Guidance On Human Genome Editing"

Bruder Consulting & Venture Group is now DHC Regenerative Medicine

Brent Morse and Amanda Mack on "Considerations for development of gene-edited PSC-based therapies"

Blake Bergam and Sara Mills on FDA's Guidance on Human- and Animal-Derived Materials in CGT

BPI: Dark Horse bolsters CGT consulting outreach with BioTechLogic acquisition

BPI: Planning, patient, and payer problems hurting gene therapy rollouts